Tamar Technologies

Tamar Technologies is a private specialty biopharmaceutical venture focused on identifying and investing in therapeutic products and technologies derived from phytochemicals. The company describes its strategy as backing scientifically supported biopharmaceutical advancements for patient use, with activity centered on Israel, the United Kingdom, and Canada. Publicly visible evidence suggests Tamar Technologies operates more as a holding, investment, and commercialization vehicle than as a fully disclosed drug developer with a broad in-house pipeline. It has been linked to sourcing and distributing pharmaceutical-grade cannabidiol API for InnoCan Pharma research programs and appears connected to investment activities through Tamar Innovest. Overall, Tamar Technologies sits at the intersection of specialty biopharma investing, phytochemical therapeutics, and strategic business development.